Close

BIO Announces San Diego to Host the World’s Largest Industrial Biotechnology Conference in 2016

BIO officially announced that the 2016 World Congress on Industrial Biotechnology will be held April 17-20, 2016 in San Diego, California at the San Diego Convention Center. BIO is also announcing the call for papers for the event. Leaders from the biotechnology, bioenergy, chemical, consumer products manufacturing, and agricultural industries as well as academia and financial sectors are invited to submit proposals and individual papers beginning September 17, 2015.

Multi-state food and ag organization letter to the White House on agriculture innovation and trade issues

Now more than ever, American agriculture needs your continued engagement with China’s President Xi Jinping on agricultural innovation and trade. The undersigned organizations embrace innovation to continue reliably supplying our valued customers in China and in other markets around the world. Sustainably meeting the challenges of global food security is important not only for China, but for all countries, and requires access to innovation and to markets. For these reasons, we ask you to make securing positive action on pending biotechnology issues a priority when you meet with President Xi in Washington, D.C. later this month. 

Kyle Bass Continues Abuse of Patent Challenge System

The Biotechnology Industry Organization (BIO) today released the following statement regarding the recent IPR challenges filed by hedge fund manager Kyle Bass.

BIO Announces Presenting Companies for 14th Annual BIO Investor Forum

BIO announced the initial list of presenting companies for the 14th Annual BIO Investor Forum, an international investor forum which explores investment trends and opportunities in life sciences. The event focuses on early and mid-stage private as well as emerging public companies that are poised for growth in 2016. The event will take place October 20-21, 2015, at the Parc 55 in San Francisco, California.

BIO Submits Comments Re: CY 2016 Medicare Outpatient Prospective Payment System (OPPS) Proposed Rule

Dear Acting Administrator Slavitt: The Biotechnology Industry Organization (BIO) is pleased to comment on the Centers for Medicare & Medicaid Services (CMS) proposed rule regarding payment policies under the calendar year (CY) 2016 hospital outpatient prospective payment system (OPPS), published in the Federal Register on July 8, 2015 (the “Proposed Rule”).  

Brief of the Biotechnology Industry Organization as Amicus Curiae supporting neither party in Rapid Litigation Management Ltd.v. Cellzdirect Inc. (Appeal from the US District Court for the Northern District of Illinois)

...

Brief of the Biotechnology Industry Organization as Amicus Curiae supporting neither party in Rapid Litigation Management Ltd.v. Cellzdirect Inc. (Appeal from the US District Court for the Northern District of Illinois)

...

BIO and PhRMA as amici curiae supporting appellants and in favor of en banc reconsideration in Ariosa Diagnostics Inc et al v. Sequenom Inc. et al (Appeals from the US District Court for the Northern District of California)

...

BIO Submits Comments on Draft EMA Guideline on Gene Therapy

The Biotechnology Industry Organization (BIO) thanks the European Medicines Agency (EMA) for the opportunity to submit comments on the “Guideline on the quality, non-clinical and clinical aspects of gene therapy medicinal products.”

BIO Announces Appointment of Brian Baenig to Lead Food & Agriculture Section

Today, the Biotechnology Industry Organization (BIO) announced that long-time agriculture policy expert Brian T. Baenig will be joining BIO as Executive Vice President, Food & Agriculture Section.